BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18288118)

  • 21. FDA pregnancy risk categories and the CPS: do they help or are they a hindrance?
    Law R; Bozzo P; Koren G; Einarson A
    Can Fam Physician; 2010 Mar; 56(3):239-41. PubMed ID: 20228306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescriptions for category D and X drugs during pregnancy in Taiwan: a population-based study.
    Kao LT; Chen YH; Lin HC; Chung SD
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1029-34. PubMed ID: 24578346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a population-based register study.
    Dehlink E; Yen E; Leichtner AM; Hait EJ; Fiebiger E
    Clin Exp Allergy; 2009 Feb; 39(2):246-53. PubMed ID: 19134022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergency contraception update: a Canadian perspective.
    Leung VW; Soon JA; Levine M
    Clin Pharmacol Ther; 2008 Jan; 83(1):177-80. PubMed ID: 18043681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ibuprofen without a prescription.
    Med Lett Drugs Ther; 1984 Jul; 26(665):63-5. PubMed ID: 6738449
    [No Abstract]   [Full Text] [Related]  

  • 26. An overview of over the counter drugs in pregnancy and lactation.
    Das BP; Joshi M; Pant CR
    Kathmandu Univ Med J (KUMJ); 2006; 4(4):545-51. PubMed ID: 18603972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of antibiotics and oral contraceptive interactions: knowledge and practice of dental surgeons.
    Arigbede AO; Adedigba MA; Adeyemi BF; Omitola OG
    Niger Postgrad Med J; 2008 Sep; 15(3):179-84. PubMed ID: 18923593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new FDA pregnancy labeling requirements for drugs.
    Frederiksen MC
    J Midwifery Womens Health; 2011; 56(3):303-7. PubMed ID: 21535377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parental preferences for FDA-approved medications prescribed for their children.
    Yoon EY; Clark SJ; Butchart A; Singer D; Davis MM
    Clin Pediatr (Phila); 2011 Mar; 50(3):208-14. PubMed ID: 21098519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy outcome after exposure to oral contraceptives during the periconceptional period.
    Ahn HK; Choi JS; Han JY; Kim MH; Chung JH; Ryu HM; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
    Hum Exp Toxicol; 2008 Apr; 27(4):307-13. PubMed ID: 18684801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of awareness among pregnant women of the effects of drugs on the fetus and mother in Iran.
    Mashayekhi SO; Dilmaghanizadeh M; Fardiazar Z; Bamdad-Moghadam R; Ghandforoush-Sattari F
    Health Policy; 2009 Jun; 91(1):89-93. PubMed ID: 19128853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cross-sectional study of drug use in pregnancy].
    Culig J; Leppée M; Stimac D; Kuvacić I; Pulanić-Klepac T; Herman R; Tuckar N; Podobnik M; Klobucar A; Matesa S; Polić-Vizintin M; Damić AM
    Lijec Vjesn; 2007; 129(8-9):253-9. PubMed ID: 18198623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
    van Staa TP; Rietbrock S; Setakis E; Leufkens HG
    J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birth defects among infants born to women who received anthrax vaccine in pregnancy.
    Ryan MA; Smith TC; Sevick CJ; Honner WK; Loach RA; Moore CA; Erickson JD
    Am J Epidemiol; 2008 Aug; 168(4):434-42. PubMed ID: 18599489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
    Nørgaard M; Pedersen L; Gislum M; Erichsen R; Søgaard KK; Schønheyder HC; Sørensen HT
    J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doctors, drugs, and the FDA.
    Shanklin DR
    J Reprod Med; 1972 Nov; 9(5):203-5. PubMed ID: 4634511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving knowledge of the teratogenicity of medications in human pregnancy.
    Adam MP; Polifka JE; Friedman JM
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):175-82. PubMed ID: 21766440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacovigilance in pregnancy using population-based linked datasets.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):211-25. PubMed ID: 19173342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug use for the pregnant or lactating patient.
    Haas DA; Pynn BR; Sands TD
    Gen Dent; 2000; 48(1):54-60. PubMed ID: 11199555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.